<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-icosapent-ethyl.xml</id>
  <title>Recalls Watch: Icosapent Ethyl</title>
  <link rel="self" href="https://recalls.watch/feed/substance-icosapent-ethyl.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2026-03-18T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/98560/</id>
    <title>Zydus Pharmaceuticals (USA) Inc: Icosapent Ethyl Capsules</title>
    <link href="https://recalls.watch/recall/fda/98560/"/>
    <updated>2026-03-18T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/98227/</id>
    <title>Zydus Pharmaceuticals (USA) Inc: Icosapent Ethyl capsules</title>
    <link href="https://recalls.watch/recall/fda/98227/"/>
    <updated>2026-01-28T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96964/</id>
    <title>Zydus Pharmaceuticals (USA) Inc: Icosapent Ethyl Capsules 1 gram</title>
    <link href="https://recalls.watch/recall/fda/96964/"/>
    <updated>2025-06-18T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Failed Tablet/Capsule specifications; a product complaint was reported for burnt or melted capsules. This was determined to be a result of oxidation by leakage of capsule contents.</summary>
  </entry>
</feed>
